Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chikanza, I. C.
Right arrow Articles by Grossman, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chikanza, I. C.
Right arrow Articles by Grossman, A. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 131-136, Copyright © 1998 by British Society for Rheumatology


REVIEWS

Hypothalamic-pituitary-mediated immunomodulation: arginine vasopressin is a neuroendocrine immune mediator

IC Chikanza and AS Grossman
Department of Rheumatology, The Royal London Hospital.

Organisms respond to a variety of environmental agents, such as those that cause inflammation, by mounting a coordinated complex series of adaptive responses involving the immune, nervous and endocrine systems. These adaptations are aimed at restoring the homeostatic balance and the return to the status quo ante. This interaction is facilitated by cytokines, hormones and neurotransmitters, as well as receptors that are endogenous to the neural, immune and endocrine systems. These shared ligands and receptors provide the molecular basis of this cross- talk. Studies of animal models of autoimmune diseases have shown that defects in the neuroendocrine immune communications contribute to the development of chronic inflammatory autoimmune disease. By analogy, similar observations have now been made in patients with inflammatory rheumatic disorders. For instance, patients with rheumatoid arthritis have abnormally low cortisol responses to inflammation, whilst the production of prolactin is excessive and dysregulated. Prolactin is a pro-inflammatory neuropeptide. This paper reviews the evidence to support the viewpoint that the neuropeptide arginine vasopressin, which is also produced by the hypothalamus, should be considered to be another neuroendocrine modulator of immune and inflammatory responses. It is also being hypothesized that the production of arginine vasopressin might be dysregulated and excessive in rheumatoid arthritis, and that this could be another additional neuroendocrine factor contributing to the pathophysiology of the disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
R. Campos-Rodriguez, A. Quintanar-Stephano, R. A. Jarillo-Luna, G. Oliver-Aguillon, J. Ventura-Juarez, V. Rivera-Aguilar, I. Berczi, and K. Kovacs
Hypophysectomy and Neurointermediate Pituitary Lobectomy Reduce Serum Immunoglobulin M (IgM) and IgG and Intestinal IgA Responses to Salmonella enterica Serovar Typhimurium Infection in Rats
Infect. Immun., March 1, 2006; 74(3): 1883 - 1889.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. C. Chikanza and D. L. Kozaci
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Rheumatology, November 1, 2004; 43(11): 1337 - 1345.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Wilson, J. J. Carmody, and J. S. Walker
The Importance of the Hypothalamo-Hypophyseal-Adrenal Axis to the Anti-Inflammatory Actions of the kappa -Opioid Agonist PNU-50,488H in Rats with Adjuvant Arthritis
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1131 - 1136.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
A. J. Chover-Gonzalez, D. S. Jessop, P. Tejedor-Real, J. Gibert-Rahola, and M. S. Harbuz
Onset and severity of inflammation in rats exposed to the learned helplessness paradigm
Rheumatology, July 1, 2000; 39(7): 764 - 771.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. J. Walker, E. Kidd, P. S. Heslop, and C. Chandler
Spontaneous ambulatory activity as a quantifiable outcome measure for rheumatoid arthritis
Rheumatology, December 1, 1999; 38(12): 1234 - 1238.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.